<DOC>
	<DOC>NCT00573469</DOC>
	<brief_summary>The purpose of this study is to determine whether treatment with D9421-C for 8 weeks in Japanese patients with mild to moderate active Crohn's disease will improve their symptoms of Crohn's disease and quality of life.</brief_summary>
	<brief_title>Efficacy and Safety Study of D9421-C 9 mg and 15 mg Versus Placebo in Japanese Patients With Active Crohn's Disease</brief_title>
	<detailed_description />
	<mesh_term>Crohn Disease</mesh_term>
	<criteria>Female or male aged ≥ 18 and ≤ 65 years Diagnosis of Crohn's Disease Having ileostomy or pouch and/or colostomy Having previous gastric surgery Having a known or suspected systemic infection</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>July 2012</verification_date>
	<keyword>gastrointestinal</keyword>
	<keyword>GI</keyword>
	<keyword>Crohn's disease</keyword>
	<keyword>Japan</keyword>
	<keyword>Japanese</keyword>
</DOC>